Drug intelligence / Profile preview

s-amlodipine gentisate

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral
01

Overview

S-amlodipine gentisate is a crystalline acid addition salt formed by reacting the active (S)-enantiomer of amlodipine with gentisic acid. It is developed to provide improved potency and safety compared to racemic amlodipine formulations. S-amlodipine acts as a calcium channel blocker of the dihydropyridine class, selectively inhibiting L-type calcium channels in vascular smooth muscle cells more than in cardiac muscle cells. This results in vasodilation, reduced peripheral resistance, and lower blood pressure. The addition of the gentisic acid moiety aims to enhance stability and maintain effective blood concentrations for longer durations after administration. S-amlodipine (levamlodipine) is indicated for hypertension and cardiovascular diseases such as angina[3][5][6][7].

Brand names
Skodipine
Other names
levamlodipine gentisateS-(-)-amlodipine gentisate saltamlodipine gentisate
02

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on s-amlodipine gentisate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on s-amlodipine gentisate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call